Literature DB >> 35103135

Infective Endocarditis Outcomes in Jeddah City, Saudi Arabia.

Mohammed H Bogari1, Aseel S Jarwan1, Abdullah O Abukhodair1, Basil A Alzahrani1, Jawad A Alsayegh1, Alaa Al-Kathiri2, Abdulhalim J Kinsara3.   

Abstract

OBJECTIVES: This study aimed to analyze all the reported cases of definitive infective endocarditis, based on the modified Duke criteria in a tertiary hospital over the past five years, focusing on the causative organism/s, predisposing factors, and outcomes.
METHODS: This is a cross-sectional retrospective study. Patients with a confirmed diagnosis of infective endocarditis using modified Duke criteria were included. The demographic data, predisposing factors, the causative microorganisms, laboratory and echocardiography results, and treatment were collected.
RESULTS: In total, 37 patients were identified, 22 were male, and the median age was 59 years. Native valve endocarditis was found in 29 (78.3%) patients. The most frequently involved valves were the mitral valve in eight (42.1%) and aortic valve in six (31.6%) patients. Fever occurred in 22 patients (59.5%). The most frequent organisms were Staphylococcus aureus in 14 (37.4%) patients, coagulase-negative staphylococci in seven (18.9%) patients, and streptococci in seven (18.9%) patients. The majority (n=27) of the patients (72.97%) were treated medically, with 10 (27.02%) requiring in-hospital surgical intervention. The in-hospital mortality rate was 24.3%. Late presentation, reluctance to undergo surgery, and the past history of rheumatic fever were the contributing factors.
CONCLUSION: Native valve endocarditis is the major type of infective endocarditis. The most frequent organisms were Staphylococcus aureus, Streptococcus, and coagulase-negative staphylococci. In our study, infective endocarditis was more common among males, surgical intervention was low, and a high in-hospital mortality rate was noted in our series.
Copyright © 2021, Bogari et al.

Entities:  

Keywords:  culture positive; duke criteria; infective endocarditis; jeddah; microbiologic; mitral valve; staphylococcus aureus; tertiary hospital

Year:  2021        PMID: 35103135      PMCID: PMC8776523          DOI: 10.7759/cureus.20556

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  22 in total

Review 1.  Diagnostic criteria and problems in infective endocarditis.

Authors:  B D Prendergast
Journal:  Heart       Date:  2004-06       Impact factor: 5.994

2.  Clinical Risk Factors for Infective Endocarditis in Staphylococcus aureus Bacteremia.

Authors:  Vincent Bryan D Salvador; Bikash Chapagain; Astha Joshi; Debra J Brennessel
Journal:  Tex Heart Inst J       Date:  2017-02-01

Review 3.  Global and regional burden of infective endocarditis, 1990-2010: a systematic review of the literature.

Authors:  Aref A Bin Abdulhak; Larry M Baddour; Patricia J Erwin; Bruno Hoen; Vivian H Chu; George A Mensah; Imad M Tleyjeh
Journal:  Glob Heart       Date:  2014-03

4.  Epidemiological and mortality trends in infective endocarditis, a 17-year population-based prospective study.

Authors:  Alberto Cresti; Mario Chiavarelli; Marco Scalese; Cesira Nencioni; Silvia Valentini; Francesco Guerrini; Incoronata D'Aiello; Andrea Picchi; Francesco De Sensi; Gilbert Habib
Journal:  Cardiovasc Diagn Ther       Date:  2017-02

5.  Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey.

Authors:  Christine Selton-Suty; Marie Célard; Vincent Le Moing; Thanh Doco-Lecompte; Catherine Chirouze; Bernard Iung; Christophe Strady; Matthieu Revest; François Vandenesch; Anne Bouvet; François Delahaye; François Alla; Xavier Duval; Bruno Hoen
Journal:  Clin Infect Dis       Date:  2012-05       Impact factor: 9.079

6.  Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer.

Authors:  Gilbert Habib; Bruno Hoen; Pilar Tornos; Franck Thuny; Bernard Prendergast; Isidre Vilacosta; Philippe Moreillon; Manuel de Jesus Antunes; Ulf Thilen; John Lekakis; Maria Lengyel; Ludwig Müller; Christoph K Naber; Petros Nihoyannopoulos; Anton Moritz; Jose Luis Zamorano
Journal:  Eur Heart J       Date:  2009-08-27       Impact factor: 29.983

Review 7.  Epidemiology and prevention of valvular heart diseases and infective endocarditis in Africa.

Authors:  Vuyisile T Nkomo
Journal:  Heart       Date:  2007-12       Impact factor: 5.994

8.  Ten-year experience of Q fever endocarditis in a tertiary cardiac center in Saudi Arabia.

Authors:  Fatehi E Elzein; Nisreen Alsherbeeni; Khalid Alnajashi; Eid Alsufyani; M Y Akhtar; Rashed Albalawi; Ahmed M Albarrag; Naoufel Kaabia; Syed Mehdi; Ahmed Alzahrani; Didier Raoult
Journal:  Int J Infect Dis       Date:  2019-08-02       Impact factor: 3.623

9.  Prevention of infective endocarditis in developing countries.

Authors:  Breminand Maharaj; Andrew Parrish
Journal:  Cardiovasc J Afr       Date:  2012-07       Impact factor: 1.167

10.  A Seventeen-Year Descriptive Study of Infective Endocarditis Features at a Tertiary, Teaching Hospital.

Authors:  Saleh A Alghamdi; Abdulaziz M Alkhammash; Abdulrahman F Alotaibi; Saeed A Bugshan; Nawaf K Alshanbri; Mohammed Zahrani
Journal:  Cureus       Date:  2021-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.